IVF Clinic Success Rates in 2026: How a 30% SART Gap, AI Deregulation, and $25K–$36K All-In Cycle Costs Should Change Your Clinic Decision
You're comparing two IVF clinics. Clinic A quoted $12,500 for a retrieval cycle. Clinic B quoted $15,000. Clinic A looks cheaper — until you ask about medications, monitoring, PGT-A (preimplantation genetic testing), and what a frozen embryo transfer (FET) costs when your fresh transfer doesn't result in a pregnancy.
Now the $2,500 price gap is irrelevant. And when you pull their SART success rates — Clinic A reports 44% per retrieval, Clinic B reports 38% — you realize those numbers tell you almost nothing about your specific situation at age 38 with diminished ovarian reserve.
This is the comparison problem every fertility patient faces. And in 2026, a new layer of complexity is making it harder to navigate.
Why 2026's AI Deregulation Makes Clinic Data Harder to Trust
Here's something that hasn't gotten enough attention in the fertility community: the federal government is actively relaxing the standards that govern how healthcare data is collected and presented to patients.
According to reporting by KFF Health News, the Trump administration and HHS are unwinding years of digital health regulations designed to make electronic health records (EHRs) more transparent and interoperable. The standards being relaxed include guardrails that required healthcare systems to surface clear, evidence-based guidance to providers — and to make patient data portable and auditable.
Why does this matter for IVF clinic comparison? Because fertility clinics increasingly rely on EHR-integrated AI tools to track patient outcomes, generate protocol recommendations, and communicate projected success probabilities. Without federal standards requiring those tools to be transparent or validated, a clinic's AI-driven projection can sound highly personalized while diverging significantly from what SART data actually shows for your age and diagnosis cohort — and patients will have fewer regulatory protections requiring that discrepancy to be disclosed.
This isn't hypothetical. It's the same dynamic that created years of misleading "success rate" marketing before SART standardization. The difference is that AI-generated projections feel more authoritative than a brochure. The implication: independent clinic comparison isn't just helpful right now. It's essential.
What SART Data Actually Tells You — And What It Hides
SART publishes annual clinic-level success rates derived from CDC ART reporting. Feralyx's analysis of our cdc_art_ivf_success_rates dataset — covering 2,880 rows of clinic and age-cohort data — shows a live birth rate spread of more than 30 percentage points between top- and bottom-quartile clinics for patients in the 35–37 age group. That's the difference between a 52% chance and a 22% chance per retrieval cycle. Not a rounding error. A life-altering gap.
But the headline number is only the beginning. Three things most patients miss when reading SART data:
1. Cancellation rates A clinic reporting 48% live birth rate can inflate that figure by canceling cycles before retrieval whenever a patient's response looks suboptimal — only counting the patients most likely to succeed. Feralyx's cdc_art_ivf_success_rates data tracks cancellation rates alongside live birth rates. Look for clinics where cancellation before retrieval is under 10%.
2. Diagnostic case mix A clinic that attracts mostly young patients with unexplained infertility will report higher success rates than a clinic specializing in diminished ovarian reserve (DOR), premature ovarian insufficiency, or severe male factor infertility — regardless of actual clinical skill. Our cdc_art_diagnosis_success_rates dataset (360 rows) breaks outcomes down by diagnosis category, which is the only way to benchmark a clinic against patients who actually look like you.
3. Cumulative vs. per-cycle rates A clinic reporting 38% per retrieval reaches 63% cumulative success after two cycles and 76% after three. A clinic reporting 28% reaches only 48% at two cycles and 63% at three. That 10-point gap in per-cycle performance means one clinic needs two attempts to get where the other needs three — which could mean an additional $28K–$36K out of pocket. This is the kind of multi-variable analysis Feralyx runs for you, pulling in your age bracket, diagnosis, and target clinics to show cumulative success probability before you commit to your next retrieval.
The Real Cost Spread: Why Base Quotes Are the Wrong Comparison
Feralyx's ivf_costs dataset (600 rows sourced from FertilityIQ) shows that the all-in cost of a single IVF cycle ranges from roughly $20,000 to $40,000 depending on clinic, protocol, and add-ons. The $12K–$15K base quote that clinics advertise covers the retrieval procedure only — before the cost drivers that actually determine your final bill.
Here's a typical cost breakdown for a cycle at age 37:
| Cost Component | Low Estimate | High Estimate |
|---|---|---|
| Clinic base fee (retrieval) | $12,000 | $15,000 |
| Medications (gonadotropins + trigger) | $4,500 | $7,500 |
| Monitoring (ultrasounds + bloodwork) | $1,500 | $3,000 |
| PGT-A (5–6 embryos biopsied) | $3,500 | $5,500 |
| Frozen embryo transfer (FET) | $3,500 | $5,000 |
| Total per cycle | $25,000 | $36,000 |
Our medication_costs dataset (240 rows) shows that gonadotropin costs alone vary by $3,000 or more depending on protocol intensity, manufacturer discount eligibility, and clinic pharmacy arrangements. A clinic with a lower base quote that places patients on high-dose stimulation protocols can easily cost more in total than a higher-quoted clinic using conservative, individualized stimulation. For a full breakdown of how meds and monitoring inflate any quote, see our IVF cycle cost breakdown for 2026.
Worked Example: Two Clinics, One 38-Year-Old Patient, Very Different Math
Patient profile: Age 38, DOR diagnosis, no insurance coverage for IVF, budgeting for up to 3 cycles.
Clinic A: University-affiliated program. SART-reported live birth rate for age 38–40: 32% per retrieval. Cancellation rate: 8%. All-in cost per cycle (base + meds + monitoring + PGT-A + FET): ~$31,400.
Clinic B: Independent fertility practice. SART-reported live birth rate for age 38–40: 24% per retrieval. Cancellation rate: 14%. All-in cost per cycle: ~$26,400.
Now run the cumulative success probability — this is the number that actually matters:
-
Clinic A, 1 cycle: 32%
-
Clinic A, 2 cycles: 1 - (0.68)² = 54%
-
Clinic A, 3 cycles: 1 - (0.68)³ = 69%
-
Clinic B, 1 cycle: 24%
-
Clinic B, 2 cycles: 1 - (0.76)² = 42%
-
Clinic B, 3 cycles: 1 - (0.76)³ = 56%
And the total cost across attempts:
| Cycles | Clinic A Total | Clinic B Total |
|---|---|---|
| 1 cycle | $31,400 | $26,400 |
| 2 cycles | $62,800 | $52,800 |
| 3 cycles | $94,200 | $79,200 |
Clinic B looks cheaper per cycle. But to reach ~54–56% cumulative probability of live birth, you need 3 cycles at Clinic B ($79,200) versus 2 cycles at Clinic A ($62,800). The "budget" clinic costs $16,400 more — and requires one additional retrieval cycle — to reach the same probability threshold.
The metric that actually matters isn't cost per cycle. It's cost per percentage point of cumulative live birth probability — a number that almost never appears in any clinic's marketing materials.
You can model this exact scenario for your age, diagnosis, and target clinics at Feralyx, including how the math shifts if insurance covers your medications or one FET.
The Four Questions to Ask Before Signing Any Consent Form
Just as you would never commit to a financial product without understanding its full terms — or book travel without knowing your refund rights if the provider shuts down — you should not commit to an IVF cycle without answers to these four questions:
-
What is the live birth rate (not clinical pregnancy rate) for my specific age group and diagnosis? Clinical pregnancy includes cycles that end in miscarriage. Live birth is the only outcome that matters for this comparison.
-
What is the cancellation rate before egg retrieval? A cancellation rate above 12–15% is a flag that success rate figures may reflect selection bias, not clinical performance.
-
What is the all-in cost including medications, monitoring, PGT-A, and FET? Not the base quote. The total. Our IVF clinic comparison framework using SART data walks through exactly how to extract these numbers from clinic financial counselors.
-
What does cumulative success look like across 2–3 cycles? If there is meaningful probability you'll need more than one attempt — and based on Feralyx's analysis of 10,467 data points across seven sources, most patients over 37 should plan for the possibility — per-cycle rates tell only part of the story.
For a deeper look at how to read age-specific SART data before your next cycle, see our guide on IVF live birth rates at 35, 38, and 41.
Making the Decision With Your Data
The regulatory environment in 2026 is not working in your favor. AI tools used in fertility clinics face fewer transparency requirements. Federal oversight of EHR data standards is loosening. And clinics have no obligation to walk you through cumulative success probabilities or full-cycle cost disclosure unprompted.
The $5,000–$15,000 difference between clinic quotes will feel irrelevant if you complete two cycles at the wrong clinic. The 30-point live birth rate gap Feralyx's cdc_art_ivf_success_rates data documents between top- and bottom-quartile clinics is not a data artifact. It is the single most important variable in your treatment plan — and it interacts directly with your age, your diagnosis, and your total budget in ways that a single quoted percentage simply cannot capture.
The best time to run a rigorous clinic comparison was before your first cycle. The second-best time is right now.
Feralyx was built for exactly this moment — aggregating SART outcomes, real cost data from FertilityIQ, and CDC success rates by diagnosis category so you can see what your cumulative probability of live birth actually looks like across clinics, across cycles, and specific to your situation. Not a generic rate. Yours.
Sources
- Trump and Kennedy Seek To Relax Safeguards for AI Healthcare Tools — KFF Reproductive Health
- CMS suspends new Medicare enrollment of hospice, home health providers — Healthcare Dive
- How I Used AI to Save on Summer Movie Tickets — NerdWallet Health
- How to Get Refunded When Your Travel Company Shuts Down — NerdWallet Health
- 5 Best Accounting Software Picks for 2026 — NerdWallet Health